Chronic Lymphocytic Leukemia

Filter By:
08:16
Speaking to the European Medical Journal from the 19th Congress of the European Haematology Association (EHA) meeting, Prof. John Seymour from Sir Peter MacCallum, Department of Oncology, Australia, outlines the three presentations at the meeting updating clinicians on the latest findings with ABT199 , an investigational B-cell lymphoma 2 (BCL-2) s...
by:PatientPowerEU | 99 views
08:13
Speaking to the European Medical Journal from the 19th Congress of the European Haematology Association (EHA) meeting, Prof. John Seymour from Sir Peter MacCallum, Department of Oncology, Australia, outlines the three presentations at the meeting updating clinicians on the latest findings with ABT199 , an investigational B-cell lymphoma 2 (BCL-2) s...
by:EMJ | 119 views
07:57
Professors Simon Rule, Peter Hillmen and John Gribben are leading UK clinical researchers with a special interest in CLL. In this brief news report from this year's EHA meeting in Milan they share insights into the promising future for CLL treatment as greater understanding of the biology of this co...
by:PatientPowerEU | 202 views
36:34
In this video from the CLLSA UK Patient Meeting in Cambridge, 21st June, 2014, Patient Advocate Andrew Schorr chairs a panel of UK patient advocates in a discussion of the important roles that advocacy can play in living with and raising awareness of less understood diseases such as CLL. From small ...
by:PatientPowerEU | 95 views
08:45
Professor Peter Hillmen from Leeds Teaching Hospital in the UK explains the latest research results as presented at the EHA on new treatments Ibrutinib and Idelalisib, and how they offer great promise for CLL patients. Keywords: CLL Chronic Lymphocytic Leukaemia Prof Peter Hillmen CLL RESONA...
by:PatientPowerEU | 178 views
26:23
This series of interviews with eight expert faculty is filmed on location during the 2014 American Society of Clinical Oncology (ASCO) Annual meeting, where the most current cancer data is presented and examined. Following the scientific sessions, Dr. James Epstein reviews and explores some of the most significant research findings in multiple tumo...
by:imedex | 218 views
05:30
Professor John Gribben from Bart’s Hospital in London explains why he is excited about promising new treatments for patients with Chronic lymphocytic leukemia (CLL) including latest on trials in Ibrutinib, Idelalisib, and ABT199.
by:PatientPowerEU | 219 views
02:59
Los pacientes con leucemia linfática crónica (CLL), cuando deciden recibir tratamiento, normalmente entran el periodo llamado de "espera y observa", que puede resultar estresante. El Dr. Javier Pinilla-Ibarz, un importante especialista de CLL en el Moffitt Cancer Center de Tampa nos explica cómo los ayuda a seguir con sus vidas mientras e...
by:patientpower | 165 views
03:22
El Dr. Januario Castro es profesor asociado del área de médula ósea y transporte de células madre del UC San Diego Moores Cancer Center y nos explica la importancia que va a tener la personalización de las terapias en el tratamiento del cáncer. Esto es debido a los avances que se han dado en el cono...
by:patientpower | 569 views
04:07
Il Dottore Giuseppe Saglio, professore de medicina interna della Università di Torino, ci dà importante novità terapeutiche sulla leucemia linfatica cronica (CLL) presentate a l'incontro annuale 2013 de la società americana di ematologia (ASH).
by:patientpower | 682 views

Top Tags



Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Oncologist 
Different type of MD 
Nurse 
Other oncology Professional 
Patient/Advocate 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.


username:   password: remember me

Sign In

Username:
Password:
Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)